IRIS
RIBOLSI, MENTORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.623
NA - Nord America 1.707
EU - Europa 819
SA - Sud America 429
AF - Africa 61
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.652
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.241
US - Stati Uniti d'America 1.587
CN - Cina 612
IT - Italia 412
BR - Brasile 311
HK - Hong Kong 261
VN - Vietnam 236
GB - Regno Unito 107
BD - Bangladesh 105
FR - Francia 102
DE - Germania 66
CA - Canada 54
AR - Argentina 47
IN - India 46
MX - Messico 46
ID - Indonesia 23
NL - Olanda 22
ZA - Sudafrica 22
EC - Ecuador 21
PE - Perù 15
FI - Finlandia 14
CO - Colombia 13
ES - Italia 13
PK - Pakistan 13
JP - Giappone 12
UA - Ucraina 11
AU - Australia 10
PL - Polonia 10
RU - Federazione Russa 10
VE - Venezuela 9
AT - Austria 8
CZ - Repubblica Ceca 8
EG - Egitto 7
KZ - Kazakistan 7
PY - Paraguay 7
TR - Turchia 7
ET - Etiopia 6
IQ - Iraq 6
MA - Marocco 6
UZ - Uzbekistan 6
EE - Estonia 5
IR - Iran 5
MD - Moldavia 5
PH - Filippine 5
MY - Malesia 4
RO - Romania 4
SE - Svezia 4
TH - Thailandia 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CL - Cile 3
DO - Repubblica Dominicana 3
HN - Honduras 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
SA - Arabia Saudita 3
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
ML - Mali 2
NI - Nicaragua 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
IM - Isola di Man 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
ME - Montenegro 1
MG - Madagascar 1
MT - Malta 1
NG - Nigeria 1
NR - Nauru 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
QA - Qatar 1
Totale 7.645
Salva come PNG Salva come JPEG
Città #
San Jose 563
Singapore 416
Ashburn 333
Rome 259
Hong Kong 252
Beijing 171
Hefei 171
Ho Chi Minh City 96
Lauterbourg 88
Boardman 83
London 82
Dallas 72
New York 59
Shanghai 51
Hanoi 49
Santa Clara 47
Los Angeles 38
Council Bluffs 33
Mexico City 29
Munich 29
São Paulo 26
Burlington 19
Milan 16
Brooklyn 13
Pune 13
San Francisco 13
Seattle 13
Buffalo 12
Haiphong 12
Amsterdam 11
Chicago 11
Frankfurt am Main 10
Johannesburg 10
Toronto 10
Washington 10
West Jordan 10
Chennai 9
Denver 9
Turku 9
Warsaw 9
Curitiba 8
Da Nang 8
Guarulhos 8
Quito 8
Rio de Janeiro 8
Secaucus 8
Biên Hòa 7
Guangzhou 7
Guayaquil 7
Las Vegas 7
Lima 7
Thái Bình 7
Campinas 6
Naples 6
Orem 6
Bari 5
Bologna 5
Catania 5
Chengdu 5
Dhaka 5
Hangzhou 5
Helsinki 5
Medellín 5
Ninh Bình 5
Paris 5
Ribeirão Preto 5
Tokyo 5
Zhuhai 5
Addis Ababa 4
Atlanta 4
Belo Horizonte 4
Bogotá 4
Brno 4
Manchester 4
Palermo 4
Phoenix 4
San Juan 4
Sona 4
Stockholm 4
Tashkent 4
Thái Nguyên 4
Vienna 4
Vĩnh Tường 4
Alvorada 3
Asunción 3
Bangkok 3
Barra Bonita 3
Bauru 3
Boydton 3
Brasília 3
Córdoba 3
Detroit 3
Florence 3
Guiyang 3
Hamburg 3
Jundiaí 3
Karachi 3
Lấp Vò 3
Madrid 3
Manaus 3
Totale 3.450
Salva come PNG Salva come JPEG
Nome #
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 240
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 235
Applying Lyon Consensus criteria in the work‐up of patients with proton pump inhibitory‐refractory heartburn 229
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 225
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 225
Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. 216
Clinical impact of proton pump inhibitor response and dependence 209
Effect of the gatekeeper reflux repair system on intra-esophageal distribution of acid reflux in gastroesophageal reflux disease patients: Relation with typical symptoms 209
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 194
Association between dietary habits and fecal microbiota composition in irritable bowel syndrome patients: A pilot study 160
Achalasia, from diagnosis to treatment 144
Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms 140
Chicago Classification v4.0 Stratifies Acid Burden and Abnormal Impedance-pH Variables Better Than Chicago Classification v3.0 Chicago Classification v4.0 and GERD 138
Application of Lyon Consensus criteria for GORD diagnosis: evaluation of conventional and new impedance-pH parameters 138
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 136
Anxiety correlates with excessive air swallowing and PPI refractoriness in patients with concomitant symptoms of GERD and functional dyspepsia 131
Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review 131
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 129
Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients 116
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux 114
Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease 114
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 107
Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting 102
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 98
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 97
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease 90
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 87
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 86
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 84
Practice guidelines on the use of esophageal manometry – A GISMAD-SIGE-AIGO medical position statement 75
On‐therapy impedance‐pH monitoring can efficiently characterize PPI‐refractory GERD and support treatment escalation 73
Esophageal chest pain resembles heartburn in reflux metrics and response to proton pump inhibitor therapy 71
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 71
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 71
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 71
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 67
Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics 67
Psychological distress in inflammatory bowel disease 67
Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD 65
The Lyon Consensus: Does It Differ From the Previous Ones? 62
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls 62
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 60
Esophageal motility disorders among elderly patients: An international multicenter study 59
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 59
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 59
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 56
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 54
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 53
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 53
Baseline impedance levels and structural and functional integrity of the esophageal mucosa: is acid still the only player? 51
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases 51
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 50
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 50
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 50
Exploring the Complex Interplay Between Ineffective Esophageal Motility and Reflux Burden 49
Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world 49
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 47
Relevance of Excessive Air Swallowing in GERD Patients With Concomitant Functional Dyspepsia and Poor Response to PPI Therapy 47
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future 47
Towards a better diagnosis of gastro esophageal reflux disease 47
Dilated intercellular space diameter as marker of reflux-related mucosal injury in children with chronic cough and gastro-oesophageal reflux disease 47
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 46
Letter to the Editor: Relevance of a Correct GERD Patient Classification Before Anti-reflux Procedures 45
New classifications of gastroesophageal reflux disease: an improvement for patient management? 45
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 45
Nutritional aspects in inflammatory bowel diseases 45
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis 44
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 44
Intercellular space diameters of the oesophageal epithelium in NERD patients: head to head comparision between light and electron microscopy 44
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 44
High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy 43
Relationship between baseline impedance levels and esophageal mucosal integrity in children with erosive and non-erosive reflux disease 43
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 43
Proximal esophageal impedance baseline increases the yield of impedance-pH monitoring for GERD diagnosis and is associated with heartburn response to PPI 42
Reflux characteristics triggering post-reflux swallow-induced peristaltic wave (PSPW) in patients with GERD symptoms 42
Editorial: inconclusive diagnosis of GERD: are new parameters in impedance‐pHmetry ready for clinical use? Authors' reply 42
Postreflux swallow-induced peristaltic wave index from pH-impedance monitoring associates with esophageal body motility and esophageal acid burden 42
Proximal esophageal impedance baseline increases the yield of impedance‐pH and is associated with response to PPIs in chronic cough patients 42
Role of Overweight and Obesity in Gastrointestinal Disease 41
PATIENTS WITH EXTRA-ESOPHAGEAL SYMPTOMS, COMPARED TO NERD PATIENTS WITH TYPICAL SYMPTOMS AND HEALTHY VOLUNTEERS, ARE CHARACTERIZED BY A HIGHER NUMBER OF REFLUX EPISODES AND HIGHER PROPORTION OF WEAKLY ACIDIC AND MIXED REFLUX 41
Exploring the association between esophageal mucosal inflammation, impaired motility, and GERD severity 40
Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus 40
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence 39
Nonachalasic esophageal motor disorders, from diagnosis to therapy 39
Should we have to include transcutaneous neuromodulation in the therapeutic GERD armamentarium? 39
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease 39
Letter: the potential link between oesophageal hypervigilance, visceral anxiety, increased swallow rate and oesophageal mucosal integrity 38
Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease 37
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 37
Editorial: Lyon consensus metrics—towards personalised diagnosis of non‐erosive reflux disease: Authors' reply 36
Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms 36
Letter: is wireless oesophageal pH monitoring the best technique to evaluate night‐time reflux? 35
Understanding the relationship between esophageal motor disorders and reflux disease 35
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up 35
Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease 35
Measurement of acid exposure of proximal esophagus: a better tool for diagnosing non-erosive reflux disease 32
Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallows 32
Oesophageal mucosal intercellular space diameter and reflux pattern in childhood erosive and non-erosive reflux disease 30
Short duration of acid exposure sensitizes the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease (NERD) patients 29
Letter: should we have to include baclofen in the GORD therapy armamentarium? 27
Totale 7.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 2 0 0 2 0 2 0 3 0 74
2022/202333 1 0 0 2 0 1 0 2 0 0 27 0
2023/2024331 5 35 42 23 18 137 3 27 3 17 15 6
2024/20253.468 39 24 117 26 42 75 62 16 230 208 1.127 1.502
2025/20263.802 355 199 298 586 171 162 889 205 288 293 199 157
Totale 7.717